Addition of the opioid peptides, [Leu]enkephalin and [Met]enkephalin, to isolated hepatocytes was shown to produce a stimulation of glycogenolysis comparable with that observed in the presence of maximal concentrations of glucagon, adrenaline or angiotensin. This stimulation was demonstrated to be the result of an activation of phosphorylase by a rapid Ca2+-dependent mechanism and was not decreased by the presence or either a-or fl-adrenergic antagonists, although it was dependent on the presence of the N-terminal tyrosine residue in the enkephalin molecule. It is suggested that this may be further evidence for specific opioid receptors in the liver. Addition of [Leu]enkephalin also inhibited lactate formation, indicating that the opioid peptides exert a concerted effect on hepatic carbohydrate metabolism to enhance glucose output. The transient nature of the effect of the enkephalins was shown to be the result of a rapid breakdown of the peptides in the incubation as a result of aminopeptidase activity, the initial product being the inactive des-tyrosine derivative.
[Leu]enkephalin also inhibited lactate formation, indicating that the opioid peptides exert a concerted effect on hepatic carbohydrate metabolism to enhance glucose output. The transient nature of the effect of the enkephalins was shown to be the result of a rapid breakdown of the peptides in the incubation as a result of aminopeptidase activity, the initial product being the inactive des-tyrosine derivative.
Although it has been established for many years that opiates exert considerable effects on hepatic carbohydrate metabolism, this has mainly been ascribed to an indirect action of the opiates, as a result of either activation of the sympathetic nervous system (Feldberg & Gupta, 1974; Dey & Feldberg, 1975) or alterations in the circulating plasma concentrations of glucagon and insulin (Ipp et al., 1978 (Ipp et al., , 1980 (Ipp et al., , 1982 Reid & Yen, 1981) . However, in addition to these indirect effects, there is now evidence to suggest that opioid peptides may influence carbohydrate metabolism directly. We have demonstrated that addition of to isolated hepatocytes resulted in an acute, dose-dependent, activation of both glycogenolysis and formation of glucose from [2-'4C]pyruvate (Allan et al., 1983 ).
This response was restricted to opioid peptides, morphine being ineffective, and was comparable in magnitude with that of either glucagon or the catecholamines. In addition to these peptides, Matsumura et al. (1984) have demonstrated that /3-endorphin is capable of stimulating both glycogenolysis and gluconeogenesis from lactate in hepatocytes from fed and starved rats respectively and have suggested that this may in part explain the sustained hyperglycaemia noted after intravenous infusion of P-endorphin into the rat. Although these responses have not been well characterized, the effect of ,B-endorphin appears to act via a cyclic AMP-dependent mechanism (Matsumura et al., 1984) , whereas the stimulation of glycogenolysis by [Leulenkephalin was independent of alterations in cyclic AMP production (Allan et al., 1983 tially by the method of Berry & Friend (1969) as described previously (Allan et al., 1983) . The cells were resuspended in Krebs-Henseleit (1932) bicarbonate buffer, pH 7.4, containing 1.5% (w/v) gelatin, to a final concentration of approx. 60mg wet wt./ml and incubated at 37°C under an atmosphere of 02/CO2 (19:1) in the presence of 0.10% (w/v) bacitracin. When the effects of cellular Ca2+ depletion were examined, the cells were washed in Ca2+-free Krebs-Henseleit bicarbonate buffer containing 1 mM-EGTA and gelatin, and the incubation was carried out in this buffer (Assimacopoulos-Jeannet et al., 1977) . The final incubation volume was 2ml, unless stated otherwise, and the incubation period with the hormones or enkephalins was as stated in the text. All hormones and peptides were added as 100-fold concentrates in 0.9% NaCl containing 1 mg of bovine serum albumin/ml. Samples of the cells plus incubation media were removed just before the addition of the hormones and also at the end of the incubation period. These were deproteinized in trichloroacetic acid (final concn. 10%, w/v) and the rate of glycogenolysis was determined by the output of glucose into the medium by using glucose oxidase (Bergmeyer & Bernt, 1974) . For the determination of lactate output by the cells, the samples were deproteinized with 2.9M-HC1O4 and neutralized with KHCO3 before assay (Gutmann & Wahlefeld, 1974) . Phosphorylase a activity was measured in the media described by Hue et al. (1975) , except that the formation of glycogen was monitored by the incorporation of [U-14C]glucose 1-phosphate into glycogen as described by Gilboe et al. (1972) . For this, 0.2ml of the cell suspension was added to 0.8ml of buffer containing 100mM-NaF, 20mM-EDTA, 0.5% (w/v) To gain more insight into the molecular mechanisms by which the opioid peptides influence hepatic carbohydrate metabolism, the concentration of lactate in the cells plus medium was also determined under the above glycogenolytic conditions. The time course is shown in Fig. 1 (b). In agreement with previous studies (Hems et al., 1978; Hue et al., 198 la,b) , the control cells showed a small steady increase in lactate production, whereas addition of glucagon produced a marked utilization of lactate by the cells, which was maintained over the entire incubation period.
Addition of [Leulenkephalin also significantly decreased lactate production over the first 10min incubation period when compared with addition of vehicle alone (P <0.002), the uptake of lactate being comparable with that produced by glucagon (P>0.05). However, after this time, a net lactate output occurred which closely paralleled that of the control cells. Although angiotensin produced a stimulation of glycogenolysis over the entire incubation period comparable with that by either (Hughes et al., 1977; Rossier et al., 1980; Gubler et al., 1982) , and is also the N-terminal sequence off.-endorphin, a peptide also known to stimulate both gluconeogenesis and glycogenolysis (Matsumura et al., 1984 Hutson et al., 1976; Cherrington et al., 1976) . To determine whether the enkephalins act via a similar mechanism or whether the enhanced glucose output is either the result of an allosteric activation of phosphorylase b or non-phosphorolytic glycogenolysis, the effect of [Met]enkephalin on phosphorylase a was determined at various time intervals after addition of the peptide to the cells. The results (Fig. 2) show that the increased glycogen breakdown induced by the enkephalins was also associated with an increase in phosphorylase a activity. The time of onset of the response was extremely rapid, an activation being apparent within 15 s after addition of the peptide to the cells. The maximal activity was achieved within 1 min and the response was sustained over 5 min. In agreement with the magnitude of the effect of the (1974, 1978) have suggested that the long-term effects of opiates on carbohydrate and lipid metabolism at the level of the liver may be through a direct interaction of the opiate with catecholamineX receptofs. The short-term effects of opioid peptides also resemble those of the catecholamines in that they are mediated by a cyclic AMPindependent mechanism and show a similar time of onset and dependence on the concentration of effector (Garrison & Haynes, 1973; Keppens et al., 1977; Assimacopoulos-Jeannet et al., 1977; Allan et al., 1983 ). Therefore we have compared the ability of a-and ,B-adrenergic antagonists to inhibit the stimulation of glycogenolysis by [Leu] enkephalin and adrenaline. The results are shown in Table   2 . Both [Leu] enkephalin and adrenaline produced a comparable stimulation of glucose output when added to the cells. Prior incubation of the cells with either the ,B-adrenergic antagonist, DL-propranolol, or the a-adrenergic antagonist, dihydroergotamine, had no significant effect on either the basal rate of glycogen degradation or the stimulated rate in the presence of [Leu] enkephalin. In contrast, dihydroergotamine abolished the effect of adrenaline, which is consistent with the response being via ac-adrenergic receptors (Tolbert et al., 1973; Hutson et al., 1976; Assimacopoulos-Jeannet et al., 1977 Binding of the opioid peptide to the fl-receptor would also appear unlikely, as DL-propranolol was without effect and the response was independent of an increase in cyclic AMP (Allan et al., 1983) . Effect ofcellular Ca2+ depletion on the stimulation of glycogenolysis by [Leu] enkephalin
The possible role of Ca2+ in the stimulation of glycogenolysis by enkephalins was investigated by depleting the cells of Ca2+ by incubation in Ca2+-free buffer containing 1 mM-EGTA, as described by Assimacopoulos-Jeannet et al. (1977) . Table 3 shows a comparison of the effect of [Leu] enkephalin with those of glucagon, angiotensin and adrenaline in normal and Ca2+-free buffer. As Table 2 . Ejject of a-and fi-adrenergic antagonists on the stimulation ofglycogenolysis by [Leu] enkephalin and adrenaline
The experimental protocol was as described in the Experimental section. The cells were preincubated for 10min before the addition of the a-and f-adrenergic antagonists (final concns. 20OM). After a further 5min incubation period, the [Leulenkephalin and adrenaline were added (final concns. 1OpM and 1 pm respectively), and the output of glucose was measured over the next 15 min. Results are expressed as means+ S.E.M. for five different cell preparations. *P<0.001 for significance of difference from appropriate controls.
Glucose respectively. The effects of Ca2+ depletion on the stimulation of glycogenolysis by glucagon, adrenaline and angiotensin were as described previously by other workers (Stubbs et al., 1976; Assimacopoulos-Jeannet et al., 1977; Keppens et al., 1977; Van de Werve et al., 1977; Chan & Exton, 1977) (Wong et al., 1974 (Wong et al., , 1978 Schwartz, 1983) , and enkephalin degradation has been reported to occur in liver homogenates (Shaw et al., 1979 These results confirm that liver has enzymes capable of degrading enkephalins and suggest that the major degradative enzyme is an N-terminal aminopeptidase, similar to the aminoenkephalinases described in brain and guinea-pig ileum (Geary et al., 1982; Hui et al., 1983) . Preliminary experiments indicate that angiotensin is not degraded by this aminopeptidase activity, suggesting that it may be specific to enkephalins and thus a means for terminating the response in vivo. In addition to providing an explanation for the short duration of the effect of opioid peptides, the rapid degradation may also explain, in part at least, the high concentration of enkephalins required to elicit the response over longer-term incubations (Allan et al., 1983) , as it is apparent from studies with glucagon that the sensitivity of the response can be increased by several orders of magnitude by inhibition of proteolysis (Garrison & Haynes, 1973) .
